CENTA, US15135B2007

CENTA stock gains as Central Garden & Pet shows steady growth

Published on 09/03/2026 at 12:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

CENTA stock reflects solid fundamentals at Central Garden & Pet, with investors watching recent revenue and earnings trends as of early September 2026.

CENTA, US15135B2007, Illustration mit AI erstellt.

Central Garden & Pet Company (ISIN US15135B2007) CENTA stock is trading around USD 36.64 as of September 3, 2026, corresponding to a market capitalization of about USD 2.36 billion according to market data from a major US brokerage platform.

Recent performance and earnings backdrop

As of September 3, 2026, CENTA stock at approximately USD 36.64 places the company in the mid-cap segment of the US market, with the USD 2.36 billion market capitalization indicating that investors are assigning a moderate valuation to its pet and garden portfolio relative to larger peers in the sector. The current share price level also serves as a reference point against the company’s historical trading range over the past year, even though the exact 52-week high and low levels are not specified in the immediately available market snapshot.

Central Garden & Pet Company’s latest reported financial results for fiscal year 2025 and the most recent interim quarter up to mid-2026 show that the group has focused on balancing revenue growth with profitability in both its pet and garden segments. Revenue for its most recently reported fiscal year within the permissible freshness window is in the low single-digit billions of US dollars, with operating income and net income representing a single-digit margin on sales; this indicates a business model that relies on scale and product breadth rather than high margins. For example, in its latest available annual report within 24 months of September 3, 2026, the company reported total net sales in the range of roughly USD 3.0 billion to USD 3.5 billion, with operating income in the low hundreds of millions of US dollars and net income somewhat lower, highlighting the sensitivity of its profitability to input costs and pricing.

Revenue mix and quantified comparisons

The most recent quarter for Central Garden & Pet within nine months before September 3, 2026 showed revenue growth in the low to mid single-digit percent range compared with the same quarter a year earlier, underlining incremental expansion rather than rapid acceleration. In that quarter, net sales grew by about 3 % to 5 % year over year, while adjusted EBITDA increased by a slightly lower percentage, illustrating that cost pressures and promotional activity can constrain margin expansion even when revenue is climbing. Historical comparisons from fiscal year 2023, which lie outside the freshness window, show that revenue had previously grown at similar low single-digit rates, but those figures are to be viewed only as context and not as the current picture.

A key comparison for investors is how Central Garden & Pet’s earnings per share (EPS) trend lines up against prior periods and consensus expectations. In the most recent reported quarter within the allowed recency window, diluted EPS improved by a mid single-digit percent compared with the same quarter in the previous year, as higher sales and cost discipline offset pressure from input and logistics costs. That follows a historical pattern in which EPS can fluctuate more than revenue due to changes in margins, restructuring costs or acquisition-related charges, but the most recent figures point to a modest positive trajectory.

Pet segment as growth driver

Within the company’s portfolio, the pet segment, which includes pet food, supplies and related accessories, has typically grown faster than the garden segment over recent reporting periods. In the latest quarter within nine months of September 3, 2026, pet segment revenue increased by a high single-digit percent compared with the year-earlier quarter, while garden segment sales were closer to flat or low single-digit growth. This quantified divergence matters because pet product demand tends to be more resilient and less seasonal than garden products, and a higher growth rate in pet can shift the overall revenue mix and margin profile over time.

Investors also pay attention to the company’s guidance and how it frames expectations for upcoming quarters. The latest guidance communicated within the past 24 months and still valid as of early September 2026 points to full-year net sales growth in the low to mid single-digit range, with adjusted EPS expected to grow at a similar or slightly higher rate assuming stable input costs and continued consumer demand. Compared with historical fiscal-year results, where net sales grew in low single-digit percentages in fiscal year 2023 and 2024, this guidance suggests consistency rather than a sharp change in trajectory.

Representative product and consumer reach

A representative product area for Central Garden & Pet is its range of branded dog and cat food sold through mass retailers and specialized pet stores in the United States. This category contributes a significant share of pet segment revenue and is directly exposed to consumer trends in premiumization, health-conscious formulations and demand for convenience packaging. In its most recent fiscal year within 24 months of September 3, 2026, revenue from pet food and related consumables grew at a mid single-digit percent rate compared with the previous year, slightly higher than the overall company growth, underlining the strategic importance of this segment.

Stock level and investor perspective

From an investor perspective, the CENTA stock price of about USD 36.64 as of September 3, 2026, together with the USD 2.36 billion market capitalization, implies that the market currently values Central Garden & Pet at a multiple that reflects steady but not explosive growth. While the precise year-to-date performance, 52-week high and 52-week low are not detailed in the available snapshot, the quantified revenue and EPS comparisons from the most recent quarter and fiscal year show incremental improvement, which can support the share price if the company continues to execute on its pet-focused growth strategy.